A new blood test could turn the tide on lengthy diagnosis times.
A breakthrough development in early-stage endometriosis diagnosis could close the gap on lengthy wait times and costly, invasive procedures.
Australian researchers at a Perth-based medical technology company called Proteomics International have published findings that point to a successful diagnosis blood test trial.